D-0137-2024 Class III Terminated

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0137-2024 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Nov 22, 2023 and is designated Class III. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Jun 27, 2024). Affected quantity: 2016 Bottles.

Recall details

Product Type
Drugs
Report Date
Dec 13, 2023
Initiation Date
Nov 22, 2023
Termination Date
Jun 27, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2016 Bottles

Product description

buPROPion Hydrochloride Extended-Release Tablets, USP (SR) 200 mg, 60 Tablets bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 47335-738-86

Reason for recall

Failed Dissolution Specifications

Distribution pattern

Nationwide

Code information

Lot HAD0630A, exp 1/2024

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0137-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0137-2024. Report a data issue: hello@regdatalab.com.